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Abstract 
Long term respiratory conditions such as asthma and chronic obstructive pulmonary disease 
(COPD) are common, and cause high levels of morbidity and mortality.  Supporting self-
management is advocated for both asthma, and increasingly so for COPD and there is 
growing interest in the potential role of a range of new technologies, such as smartphone 
apps, the web, or telehealth to facilitate and promote self-management in these conditions.  
Treatment goals for both asthma and COPD include aiming to control symptoms, maintain 
activities, achieve the best possible quality of life, and minimise risks of exacerbation.  To do 
this health professionals should be: a) helping patients to recognise deteriorating symptoms 
and act appropriately; b) promoting adherence to maintenance therapy; c) promoting a 
regular review where triggers can be established, and strategies for managing such triggers 
discussed, and d) promoting healthy lifestyles and positive self-management of symptoms. 
In particular, low uptake of asthma action plans is a modifiable contributor to morbidity and 
possibly also to mortality in those with asthma and should be addressed as a priority.  Using 
technology to support self-management is an evolving strategy which shows promise.  This 
review provides an overview of self-management support, and discusses how newer 
technologies may help patients and health professionals to meet key treatment goals.  
Key words: asthma, self-management, inhaled corticosteroid, telehealth, digital, COPD.  
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INTRODUCTION 
Long term respiratory conditions such as asthma and chronic obstructive pulmonary disease 
(COPD) are common, with reported worldwide prevalence rates of almost 5% for both.1  
COPD is associated with high morbidity and high rates of hospital admissions, and is the 
third leading non-communicable disease cause of death worldwide.2  Asthma is also 
associated with a significant symptom burden, and worldwide, the number of disability-
adjusted life years lost due to asthma has been estimated at 15 million per year, similar to 
that for diabetes.3  Both asthma and COPD are life-long and are associated with 
considerable morbidity, mortality and health resource use, along with higher than expected 
levels of comorbidity.4  While asthma and COPD are controllable with pharmacological and 
non-pharmacological treatment strategies, they are not curable; so many people live for 
many years with the consequences of these conditions and need to efficiently self-manage 
their illness in order to achieve optimal outcomes. 
There is good evidence for effectiveness of self-management in asthma,5 and increasingly so 
for COPD, in improving outcomes.6-8  However, the challenges of implementing self-
management into routine clinical practice are considerable,9, 10  with many patients lacking 
adequate self-management training and support, and many professionals lacking time, skills 
or motivation to support self-management in patients.  Newer technologies such as 
telehealth and digital interventions are increasingly seen as potential modalities for 
providing self-management support in a more acceptable, efficacious and cost-effective 
way.  Telehealth refers to healthcare provided ‘at a distance’ via the use of technology while 
“digital intervention” refers to any intervention delivered by digital technology which would 
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include web-based interventions on PC or mobile devices, apps on smart phones, and 
interventions delivered by text messages or interactive voice recognition (IVR).11 
This review provides an overview of self-management of these chronic respiratory 
conditions, and discusses strategies to support behaviour change, considering the potential 
role for digital interventions to promote this.  
WHAT IS THE ROLE OF SELF-MANAGEMENT IN CHRONIC 
RESPIRATORY DISEASES? 
The evidence base supporting self-management is compelling for asthma,5 and recent 
studies are clarifying the effectiveness in COPD.6, 8  As a result, supporting self-management 
is a crucial aspect of best care for those diagnosed with a chronic respiratory disease.7, 12 
The treatment goals for asthma and COPD are broadly similar, aiming to control symptoms, 
maintain activities and minimise risks of exacerbation.12, 13  Asthma is characterised by 
reversible airflow obstruction and variable symptoms, which are often underestimated by 
patients.  Therefore optimising symptom control is a key goal, with the aim that patients 
should lead a full, active and unimpeded lifestyle.  COPD, however, is characterised by 
irreversible airflow obstruction and associated lung damage, so persistent symptoms are 
usual, although slightly variable in severity.  The aims of management are optimisation of 
symptoms and risk control, and improving quality of life.  These treatment goals are not 
currently achieved in either condition, and care of patients with asthma and COPD is often 
suboptimal.3, 14-16   
Cochrane reviews have shown that optimum self-management for individuals with asthma should 
include a combination of regular health professional review with provision of self-management 
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education and an agreed written action plan, (
 
Figure 1) as this will improve outcomes for both patients (fewer symptoms, less limitation in 
activity, fewer days off school/work, improved quality of life) and for health services (fewer 
contacts, less hospitalisation).6, 17, 18 
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Figure 1 Components of optimum self-management in asthma 
 
 
Focussing on COPD, a recent Cochrane systematic review has demonstrated that self-
management improves health related quality of life (QOL), reduces respiratory-related 
hospital admissions, and improves levels of dyspnoea.8  However due to heterogeneity they 
were unable to be specific about what was the most effective form and content of self-
management in COPD and it is clear that the evidence supporting self-management in COPD 
is more mixed than for asthma.19  At present guidelines advise that optimum self-
management in COPD focuses on the importance of smoking cessation, reducing exposure 
to indoor and outdoor pollution, promoting physical activity and healthy diet, adherence to 
pharmacological therapies, and improving uptake of vaccinations.  Pharmacological action 
plans are sometimes recommended in specific contexts such as supported discharge and 
exacerbation self-treatment with patient-held antibiotics and/or oral steroids, because 
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evidence for their widespread use has not been established and there is no evidence that 
altering inhaled regimes in response to worsening symptoms can prevent exacerbations.8 12, 
20 
IMPLEMENTING SELF-MANAGEMENT – WHAT IS 
IMPORTANT? 
Common to both asthma and COPD is a need to improve knowledge and understanding of 
the condition as part of the package of self-management education.  Broadly this involves 
promoting the following behaviours: 7, 12, 21 
1. Recognising a deterioration in symptoms (self-monitoring) and reacting 
appropriately 
2. Adhering to maintenance therapies 
3. Stopping smoking, avoiding triggers 
4. Health professional review  
5. Healthy lifestyle promotion (exercise, diet, stress reduction, relaxation etc.) 
As part of promoting these behaviours, health professionals should focus on empowering 
patients to take control of their illness and manage their symptoms, emphasising that 
improved quality of life can be the resultant outcome.   
However, many people with chronic respiratory disease underplay their symptoms in order 
to avoid accepting their diagnosis, mistakenly attribute symptoms to other causes, adopt 
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sedentary lifestyles or believe that their symptoms are normal for them or cannot be 
improved.22, 23  It is therefore understandable that when people do not attribute their 
symptoms to an underlying disease process, they are more likely to consider that the advice 
provided to them is irrelevant.  Facilitating a shared understanding of what symptoms a 
person is experiencing and what is realistic for them to achieve with regular therapy is an 
important place to start. 
Recognising deterioration in symptoms 
Recognising deterioration in symptoms is important as timely intervention can potentially 
avert progression to a severe exacerbation.6, 24, 25  The evidence for effectiveness of self-
monitoring of symptoms is more evident for asthma patients than those with COPD.6, 18, 25-27   
It is interesting to note that the latest UK BTS-SIGN Asthma guideline 7 has moved away 
from the term ‘self-monitoring’, using the term ‘recognition of deteriorating symptoms’ 
instead.  An analysis of exacerbations (n = 425) within a large RCT of asthma treatments 
found that participants displayed evidence of deteriorating asthma control (a decline in PEF, 
increase in symptom scores or increase in reliever use) occurring gradually and progressively 
for 5-7 days followed by a more rapid change over the 2-3 days before the exacerbation.28  
Other studies have found similar results, implying that there is a ‘window of opportunity’ to 
initiate treatment to prevent progression to a severe exacerbation.29  Unfortunately most 
patients lack action plans and an effective way of improving uptake of self-monitoring 
remains elusive.25, 30, 31}  New technologies, such as smartphone and tablet computer apps 
could be used to address these issues, but the evidence for effectiveness remains unclear.32  
Additionally, even when self-management occurs, the resulting behaviour is sometimes not 
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appropriate or in accordance with the prior agreed action plan,33 even in the context of 
asthma clinical trials when presumed exemplary education on self-monitoring is provided.23 
Provision of an asthma action plan can support patients to self-monitor by providing written 
advice about recognising deteriorating symptoms and instructions on how to alter 
medications appropriately or when to seek help.27, 34  Discussing and agreeing an action plan 
is a collaborative activity between a patient and a clinician and so takes time.  Unfortunately 
the evidence is clear that they are not being used regularly, with the majority of patients 
lacking an action plan, which in some cases leads to  potentially preventable deaths.30  A 
systematic review focussing on barriers and facilitators of asthma plan use found that 
patients and carer’s often perceive that health professionals do not acknowledge the 
experience they have of managing their own condition already, and that the action plans 
provided were sometimes felt to be irrelevant to their own illness.35  Additionally, health 
professionals may not offer action plans to all individuals with asthma, selecting those they 
believe capable of understanding an action plan, or those with milder asthma.35 
Self-monitoring by individuals with COPD is recommended, although less emphasised in 
guidelines, due to less evidence of effectiveness.12  This is particularly true of action plans 
which are often only recommended in the immediate post discharge situation as part of 
more extensive case management.  However, they are also sometimes provided to patients 
at risk of exacerbations in conjunction with self-held antibiotic and oral steroid courses, 
despite the absence of a firm evidence base.12  Self-monitoring in COPD, if used as an aid to 
self-management, should be symptom based, as changes in physiological variables (i.e. lung 
function) do not allow differentiation between an exacerbation and normal variability in the 
condition.24, 26 
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Technological advances have been employed in recent trials to promote self-monitoring in 
asthma.  One example is using a sensor on a reliever inhaler to detect increasing use, 
communicating via Bluetooth to a smartphone to trigger alerts.36  It seems plausible that 
this type of ‘passive’ monitoring may be acceptable to patients in the future and may lessen 
the treatment burden associated with self-management and self-monitoring, thus 
potentially increasing adherence.37 
Therefore although the evidence quoted above shows that asthma self-monitoring, in 
association with a written action plan, is best practice, it is clear that new strategies to 
increase uptake are needed.  Several systematic reviews have highlighted that for such 
interventions to be effective they have to consider patient, professional and organisational 
issues, a feature which is not commonly found in published interventions to date.38-40 
Promoting adherence to maintenance therapies. 
Non-adherence with maintenance therapy is common in people with long-term conditions, 
including lung disease.  When faced with patients with chronic respiratory diseases it is 
important to consider whether they are taking medications as prescribed, and to try and 
assess levels of adherence and understand reasons for non-adherence in a non-judgemental 
way .41 
Taking medicines as prescribed in asthma and COPD is crucial to avoid exacerbations, 
improve day-to-day control, and reduce the risk of hospitalisations and death.42, 43  For 
example, in asthma falling levels of adherence to inhaled corticosteroids ICS is associated 
with progressively poorer outcomes, with evidence that for every 25% increase in time 
without ICS, the rate of asthma related hospitalisation doubles.44  Population mean 
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adherence rates to ICS are low, usually reported at 30-50%, with marked variability between 
patients.45 
Not taking medications as prescribed can be intentional or unintentional.  Common reasons 
for unintentional non-adherence are poor inhaler technique and forgetting to take 
medication.41  Electronic reminder systems show promise in the case of unintentional non-
adherence due to forgetfulness, but seem unlikely to be effective in those intentionally non-
adherent and as yet there is no robust evidence relating to their benefits, in terms of long 
term adherence or improvements in clinical outcomes.46-48  Inhaler technique problems are 
compounded by an ever increasing array of inhalers,49, 50  with evidence that health 
professionals can be as confused as patients.50  Checking inhaler technique is an essential 
part of any review.  Instructional videos have been shown to be an effective way of 
improving correct inhaler use, particularly in those with limited health literacy,51  and may 
be a useful option particularly where placebo inhalers are unavailable. 
A qualitative synthesis by Pound et al,52  provides a detailed exploration of ‘why’ people do 
not take medicines as prescribed.  Many prefer not to take medicines at all where possible, 
with contributory factors being:  1) doubts about the need for the medications in the first 
place (in asthma specifically, this is compounded by a reluctance to accept the diagnosis); 
and 2) concerns about potential side effects of treatments.  Actively establishing underlying 
concerns during a review is essential to address adherence issues. 
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Lifestyle advice & triggers 
Typical triggers for inducing symptoms in those with asthma or COPD are cigarette smoke, 
other environmental irritants such as air pollution, allergens, infections, exercise and certain 
medications (for example non-steroidal anti-inflammatory drugs, beta-blockers and aspirin). 
The benefits of stopping smoking and achieving a smoke free environment are clear in both 
asthma and COPD, and for those with COPD, smoking cessation influences the natural 
history of the disease.53-55  Despite this, 1/3 or more of patients with COPD continue to 
smoke, and smoking rates in people with asthma are similar to those of the general 
population.  Documentation of smoking status and provision of smoking cessation support is 
a vital component of clinical care in asthma and COPD.  Going forward technology 
supported interventions such as txt2Stop may be increasingly considered.56 Infections are a 
well recognised trigger for both asthma and COPD, and promoting uptake of vaccinations is 
considered best practice.  While handwashing to reduce spread of infection has always been 
advocated, there is now firm evidence that this does reduce spread of respiratory 
infections.57  Advice on avoidance of other triggers is less clear cut.7  For example, UK 
asthma guidelines discuss the potentially paradoxical effects of removing a pet from the 
home: it may improve symptoms, however removal of the allergen source also reduces the 
opportunity for tolerance developing, which itself may reduce symptoms.7  House dust 
mites are a trigger for some individuals, however both chemical or physical methods of 
reducing house dust mites have been shown to be ineffectual, and therefore advice to these 
individuals may revolve more around promoting adherence to ICS.  Regarding exercise, 
appropriate pharmacological therapy, in particular using beta agonists before exertion, 
should allow most of those with asthma to continue to exercise.  While exercise training has 
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not been shown to specifically improve asthma outcomes, it does improve cardiovascular 
fitness, and should be advocated as part of general healthy lifestyle measures.7  New 
technologies that promote physical activity monitoring such as ‘Fitbit’ and ‘JawboneUP’, 
may prove useful as a means to promote activity, but this remains an evolving area.58  For 
those with COPD there is good evidence that pulmonary rehabilitation classes relieve 
symptoms such as dyspnoea and fatigue, and improve emotional functioning and their 
uptake should be promoted at every opportunity59 and in recent times pulmonary 
rehabilitation via telecare has been increasingly advocated as a potential way to deliver such 
services.60  With asthma, stress and anxiety can be a trigger for some individuals and there is 
higher prevalence of psychological problems in those with asthma.4, 61  Those with anxiety 
and depression tend to have poorer outcomes, so establishing the presence of these 
comorbidities and discussing management strategies is an important aspect of asthma 
care.61  A similar link between depression and COPD is well recognised, and worth exploring 
during consultations.4, 62  As web based Cognitive Behavioural Therapy (CBT) or Apps 
become increasingly available this provides another therapeutic option to offer, which 
might be particularly useful for those for whom lack of time is a significant barrier to 
accessing such services.63, 64 
Establishing triggers with patients with asthma or COPD at a review, and discussing person 
specific strategies for reducing their impact is an important part of self-management 
education, but must be tailored to the individual. 
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Health professional review 
Self-management support should be provided by clinicians in addition to regular clinical 
review, and self-management advice reviewed and reinforced at regular (e.g. annual) 
checks.  In asthma, provision of an action plan is only shown to be effective in conjunction 
with a regular health professional review.6, 65  At present, regular professional review often 
means a face to face, pre-arranged appointment.  However not all patients are willing or 
able to attend, particularly given most people perceive themselves as being well, so 
attendance is variable.  In the UK National Review of Asthma Deaths published in 2014, only 
57% of those who died had evidence of a routine asthma review in the preceding year.  As 
well as patient barriers to the asthma review, professional barriers also exist.  Health care 
professionals (HCP) report only providing asthma action plans to select groups of patients 
e.g. those who are well educated, or already well controlled, potentially missing the 
majority with potential to benefit.35  Lack of time, and confidence in own ability to discuss 
action plans and self-management education have  been identified as important issues for 
health professionals.40 
One aspect of the health professional review which is difficult to quantify is the impact of 
the quality of the clinician-patient relationship on outcomes.  Improving the patient 
professional relationship may be a modifiable factor influencing whether a person self 
manages effectively or not.  A recent qualitative study of adults with asthma in the USA,66 
reported widespread over reliance on reliever inhalers across those with uncontrolled and 
controlled asthma.  However, those who were uncontrolled described a poorer relationship 
with their health care providers, feeling that their provider did not listen to them and this 
patient group rejected self-management advice.  This group were also more likely to 
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attribute effects such as weight gain to a side effect of ICS.  In contrast, the controlled group 
reported feeling engaged with their health provider.  The importance of this relationship is a 
strong theme generated from a comprehensive systematic review on barriers to self-
management in asthma, which also demonstrated that patients with positive relationships 
with health care providers have less emergency department attendances, and are more 
likely to adhere to self-management advice in general.40 
CAN TECHNOLOGY IMPROVE SELF-MANAGEMENT? 
Self-management in chronic respiratory diseases improves outcomes but how best to 
improve uptake on a day to day basis remains unclear.  The traditional method of self-
management support and education during face to face reviews only works in a proportion 
of individuals and the lack of support between reviews may be a barrier to sustained 
engagement with self-management.21  There is increasing interest in using technology to 
improve uptake of self-management behaviours.  This might work by facilitating  
alternatives  to face-to-face reviews (such as via telephone),67 or as a way of providing 
ongoing tailored information and support between reviews, such as with digital 
interventions, as illustrated in Figure 2 below.  Digital interventions to promote self-
management behaviours may work completely independently from health professionals 
through the provision of automated tailored advice generated by the intervention based on 
information provided by the patient.68  More commonly, digital interventions are used as 
telehealth interventions, where patients provide clinical data to a health professional in a 
different location, who reviews it and provides tailored advice back (via the intervention), 
for example based on oxygen saturation levels or peak flows.25, 69  The majority of digital 
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interventions published to date include a telehealth component, with completely 
standalone digital interventions in the minority.68-70  
  
Figure 2  Difference between digital interventions that provide automated tailored advice and 
telehealth interventions 
 
There appears to be a divergence in the use of technology when investigating its’ role in 
supporting self-management of chronic respiratory diseases, with telehealth being the most 
popular modality for COPD, but with asthma digital interventions generally including 
automated advice, often supplemented with additional health professional input.68  This is 
possibly driven by the increased evidence and experience of using action plans in asthma, 
which lend themselves well to algorithm based digitally generated advice. 
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There is also burgeoning literature for digital interventions supporting lifestyle and 
behaviour change as part of optimum self-management, e.g. interventions supporting 
stopping smoking and increasing physical activity.71-74   
Technology and COPD 
In 2011 McLean et all provided a clinical overview of telehealthcare for long term conditions 
(COPD, heart failure and diabetes), noting that telehealthcare interventions were 
proliferating rapidly, although underpinned by variable quality of evidence.75  They reported 
some isolated examples of success, particularly in those with severe chronic diseases such 
as problematic asthma and diabetes that it could reduce hospital admissions, without 
increasing mortality, and suggesting that less complex interventions may be more cost-
effective.  They also detailed potential pitfalls associated with introducing telehealthcare 
such as enduring technical difficulties, safety concerns (data loss, confidentiality), potential 
adverse effects on  workload  and negative effects on patient-professional relationships.  A 
Cochrane review focussing on COPD reported more convincing findings,69 with evidence of 
improvements in quality of life and  Emergency Department (ED) attendances, although 
noting that these telehealth interventions were often part of a larger complex intervention 
so that teasing out which elements were effective was not possible.  These findings mirror 
that of the UK government funded Whole Systems Demonstrator (WSD) project which 
investigated the role of telehealth and telecare technologies in chronic disease management 
and included the world’s largest RCT of telehealth involving 6191 patients with diabetes, 
COPD or heart failure.  Across the three chronic diseases participants (disease specific data 
is not available for these outcomes), it showed some reductions in emergency admission 
rates, length of admission, markedly reduced mortality rates (4.6% vs 8.3%, p < 0.001),76 but 
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overall was not found to be cost-effective.77  While across the WSD study there was no 
improvement in QOL and psychological outcomes,78 published COPD specific sub group data 
reports disease specific QOL  and psychological outcomes showing that for those in the 
intervention arm there was a consistent trend to improved health related QOL, along with 
better emotional functioning and mastery, which improved over time.79  This partly matches 
the earlier Cochrane review which while showing no benefit in mortality, did demonstrate 
improved QOL and reduced ED attendances.69  
Pinnock et al,80 evaluated integrating a COPD telehealth intervention into existing clinical 
services with both control and intervention groups having care from the same clinical 
provider.  They found no difference in their primary outcome, time to first admission, or in 
any secondary outcomes (including disease specific quality of life and length of admission).  
As well as the mixed results regarding effectiveness, the review by McLean et al,75 
highlighted potential negative implications on the patient-provider relationship, including 
reinforcement of historical power relationships with ‘passive patients being monitored by a 
now distant medical professional’.  However qualitative studies report that patients are 
mostly positive about their experiences, reporting that they felt safer and that they had 
learned more about their condition, and staff felt that the improved knowledge could be a 
useful long term benefit.81  Earlier qualitative work had also suggested that interacting with 
a telehealth intervention and receiving feedback from the health professional can increase 
satisfaction in relation to factors such as continuity of care, understanding of symptom 
variability, and encouragement of self-management behaviour.82  While participants were 
mostly positive about their role in telemonitoring, several were glad to hand their devices 
back at the end of this short (3-6 month) study, stating they were getting bored using it 
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every day.  This raises the question about long term sustainability of such interventions 
requiring regular work by the patients that increase their overall treatment burden.37   
Qualitative studies suggest that COPD telehealth interventions should complement rather 
than replace current clinical care, supporting and encouraging self-management, and that 
interventions which are specifically developed to be intuitive and easy to use can overcome 
perceived barriers to using technology by those with little experience of it.82 
The uncertainties over telehealth in COPD are such that it is not clear  how it would work in 
real life settings, and future research needs to be clear about the aims and structure of the 
telehealth interventions, and  to consider implementation issues from the outset.83  If 
telehealth is to be effective then it must not add to the burden of treatment that patients 
already endure.84  There are suggestions from qualitative, but not quantitative studies, that 
there may be a group of patients for whom telehealth reduces the burden of disease and 
increases confidence.81, 82, 85  Strategies for establishing who is most likely to benefit from 
telehealth interventions is another important gap in the available evidence. 
Other uses of technology in COPD include the provision of information or support online, for 
example via social media.  Many disease based charities such as the British Lung Foundation 
or American Lung Association have a linked Facebook page or website, with forums where 
users can ask questions and hear about experiences of other others with similar problems.  
These may be useful for practical queries that users may have, for example, 
recommendations for a suitable back pack for carrying home oxygen.  However a quick 
review of such sites shows evidence of potentially harmful advice being posted by other 
users.  For example one user requesting advice due to experiencing increased shortness of 
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breath and cough, was advised to drink plenty of water to ‘thin the phlegm down’.  
Following such advice would have detrimental effects if heart failure was the underlying 
pathology.   
‘You Tube’ is another commonly used source of information and COPD is one of the few 
disease areas where the quality of information provided on You Tube has been formally 
evaluated.86  Unsurprisingly they report the quality as mixed: 70% of the 223 patient 
education videos they evaluated demonstrated high scores providing quality and 
trustworthy health information, but 20% were very poor.  This suggests that clinicians may 
want to find videos they have looked at themselves to ensure they are suitable, and be 
specific in recommendations.  Regardless of the quality of these videos, the authors note 
that there was very little evidence of user engagement with them in the form of ‘likes’, 
marking as a ‘favourite’ or saving to their own accounts.  This is not evidence that there is 
no demand, as further work by these authors provide evidence of unmet need in this area.87  
Importantly, it should be noted that “engagement” is unlikely to be accurately assessed by 
counting clicks on a “like” button and so it is clear that more research is needed in this area. 
Technology and Asthma 
A Cochrane review focussing on telehealth in asthma concluded that the likelihood of 
clinically meaningful benefits in those with mild to moderate asthma was low, with more 
potential demonstrated in those with severe disease.25  As alluded to above, there is more 
interest in the role of digital interactive interventions for supporting self-management in 
asthma, which are inexpensive to produce in comparison with professional care and so have 
the potential to be cost effective.  The literature on asthma interventions is broader, with 
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interventions assessed including telehealth, but also other digital interventions including 
apps, simple reminders, and interactive voice response interventions to name a few.  A 
systematic review of automated digital interventions to support self-management for adults 
with asthma concluded that there was some evidence of effectiveness, but that 
understanding of the active ingredients of such interventions was not possible due to lack of 
detail in the descriptions, particularly as there was little evidence that intervention 
development had been theory informed.68  A later systematic review also found that the 
majority of interventions did not use any theoretical frameworks or guidelines to inform 
their design.88  With increasing emphasis on the importance of theory informed 
development,9 it may be that the evidence picture becomes clearer over the next decade. 
In 2012 Huckvale et al reviewed 72 freely available smart phone applications ‘apps’  looking 
at three domains: comprehensiveness of asthma information, consistency of advice with 
evidence and compliance with health information best practice principles.89  
Disappointingly, no apps were found to contain comprehensive evidence based advice, and 
in 32 of 72, advice provided was not supported by evidence, concluding that improvement 
was required before clinicians could recommend such apps.  A recent update to that review 
has reinforced the message that questions about clinical quality and safety persist.90  A 
Cochrane review focussing on the effectiveness of smartphone and tablet apps for asthma 
self-management in comparison to traditional methods of delivery found only two RCTs and 
inconclusive results.32   The disparity between the number of available apps (72) and the 
published evaluations (2) is an issue when discussing using such tools with patients.  As with 
advice about websites or you tube videos clinicians would need to explore them individually 
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to ensure they are safe until such time as there are available apps which have been 
rigorously developed, and formally evaluated. 
Other studies have investigated specifically the role of electronic medication reminders, 
which would seem to have particular utility when unintentional non adherence is the issue.  
Tao et al  included four asthma studies; three used text messages and one used a pager like 
device with audio-visual reminder (green light and beep).91  Pooled results from these four 
asthma studies demonstrated a small but statistically significant positive effect on patient 
adherence to medication with the use of reminders.  Overall, they also noted that trials with 
smaller sample sizes had larger effect sizes, and that given three of the four asthma trials 
were small (<100 participants) this effect needs to be interpreted with caution.  Additionally 
the asthma studies also used additional self-management tools (information, advice, 
tailoring) so it is impossible to separate out the active ingredient.  Their main conclusion was 
a call for more adequately powered good quality trials, which is the conclusion of most 
other systematic reviews in the field.32, 92 
There is little evidence of effectiveness or information about user experiences from asthma 
or COPD-related social media use, although the number of Facebook pages suggest they are 
well used.  The UK patient charity Asthma UK has an active and well visited Facebook page, 
with the option of responding to clinical queries posted online by advising users to phone 
their helpline for advice.   
FUTURE DIRECTIONS 
Support for self-management aims to improve outcomes in a number of ways: improved 
recognition of deteriorating symptoms, more appropriate responses to exacerbations, 
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improving adherence (intentional and non-intentional) to medication, and empowering 
patients to take control of their illness.8, 79, 93, 94 
As a treatment strategy, self-management support is not offered enough by health 
professionals, or utilised enough by those with the potential to benefit.30, 35  Health 
professionals need to develop a more patient-centred approach, recognising the importance 
of a positive patient-provider relationship if outcomes are to improve.35, 39, 40, 65, 94, 95 
Technology has potential to facilitate effective self-management, particularly around ways 
of reducing the burden of self-management such as with passive monitoring, improving the 
delivery of self-management education, and the development of more sophisticated 
interactive interventions which can provide safe and clinically appropriate advice directly to 
the user 24 hours a day.  Research into digital interventions to support self-management is 
still in its infancy, and previously evaluated interventions have not always been developed 
using best practice.  The key will be ensuring future interventions are developed using best 
available evidence, are ‘person-based’ (i.e. developed with adequate attention to user 
experience), robustly evaluated, and with implementation issues considered from the 
beginning including at patient, professional and organisational levels.39, 40, 96, 97  
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